-

Orfit® Aerial® Couch Top for Proton Therapy Validated by Mevion Medical Systems

LITTLETON, Mass.--(BUSINESS WIRE)--Today, Mevion Medical Systems and Orfit Industries are pleased to announce that the Aerial® Couch Top is validated for use on the MEVION S250® Series Proton Therapy Systems.

“Mevion is committed to providing customizable and complementary immobilization products to our customers and we are excited to partner with Orfit to add the Aerial Couch Top and accessories to our proton therapy systems,” said Ying Xiong, vice president of product management at Mevion Medical Systems.

The Aerial Couch Top combines precise and reproducible immobilization with homogeneity over the entire treatment area. With no rails or other obstructions below the extension, this recently US FDA cleared couch top minimizes the air gap, improving penumbra and plan quality. Aerial extensions are available for extracranial treatment and brain, head, and neck treatments when used with Orfit HP PRO masks. The use of 3-points single layer HP PRO masks can reduce target margins to 1 mm.

“The design of the Aerial is in line with the highest technical and safety standards, without being overly complex, so that it helps assure the best possible clinical outcome for patients. This couch top perfectly pairs with advanced proton therapy systems, such as MEVION S250i,” states Emilie Cuypers, product manager radiation oncology at Orfit.

Together, we are pleased to make this entirely new couch top available as of September 2020 to current and future Mevion operated proton therapy centers.

About Mevion Medical Systems

Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and China. For more information, please visit www.mevion.com

Follow us on Twitter: @MevionMedical
Connect with us on LinkedIn: Mevion Medical Systems
Like Us on Facebook: MevionMedical

About Orfit

Orfit Industries brings high precision and comfort to the positioning and immobilization of cancer patients in Radiation Oncology. For more information, go to www.orfit.com or follow us @orfitindustries on LinkedIn, Instagram, Facebook and Twitter.

Contacts

Mevion Medical Systems Media Contact
Melanie Benton, Sr. Marketing Project Manager
mbenton@mevion.com
978-540-1551

Orfit Industries Media Contact
Chloé Cuypers, Marketing Communications
chloe.cuypers@orfit.com

Mevion Medical Systems


Release Versions

Contacts

Mevion Medical Systems Media Contact
Melanie Benton, Sr. Marketing Project Manager
mbenton@mevion.com
978-540-1551

Orfit Industries Media Contact
Chloé Cuypers, Marketing Communications
chloe.cuypers@orfit.com

Social Media Profiles
More News From Mevion Medical Systems

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, the global leader in compact proton therapy, today announced that it has been selected to deliver the MEVION S250-FIT Proton Therapy System™ to Istituto Nazionale Tumori IRCCS Fondazione G. Pascale in Naples. The award, made following a competitive European tender, will establish the first proton therapy center in Southern Italy, significantly expanding access to advanced radiation therapy for patients across the region and reducing the...

Mevion to Bring MEVION S250-FIT™ Proton Therapy System to Multidisciplinary Care Setting

BOSTON--(BUSINESS WIRE)--Mevion Medical Systems, a leader in compact proton therapy solutions, today announced that Dana-Farber Cancer Institute will install the MEVION S250-FIT Proton Therapy System™ at its Longwood Medical Area campus. The installation will integrate proton therapy directly into Dana-Farber's multidisciplinary care environment, including pediatric care delivered through the Dana-Farber/Boston Children's Cancer and Blood Disorders Center. “Proton therapy is a critical tool in...

Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 2026

LITTLETON, Mass.--(BUSINESS WIRE)--Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatm...
Back to Newsroom